ERBB2 and breast cancer: Various hematologic, neurologic, cardiac, and cognitive morbidities have been reported in patients with HER2pos BC undergoing chemotherapy combined with HER2-targeted agents.12 13 Consequently, de-escalated strategies (eg, chemo-sparing) are being developed.